SCHEMBL21089196

SCHEMBL21089196

Oc1ccccc1-c1nc2c(-c3ccccc3)cccc2s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RET P07949 1/20 0.49
FLT1 P17948 1/20 0.49
KDR P35968 1/20 0.49
MAPK14 Q16539 1/20 0.49
HSD17B10 Q99714 3/20 0.48
ALDH1A1 P00352 2/20 0.48
HPGD P15428 2/20 0.48
BCL2L1 Q07817 1/20 0.48
APP P05067 2/20 0.47
RAB9A P51151 6/20 0.45
SMN1; SMN2 Q16637 5/20 0.45
CASP3 P42574 2/20 0.45
SENP8 Q96LD8 2/20 0.45
SENP7 Q9BQF6 2/20 0.45
SENP6 Q9GZR1 2/20 0.45
NPC1 O15118 4/20 0.44
KDM4E B2RXH2 2/20 0.44
MAPT P10636 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ILK Q13418 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27670304 0.87 PDPK1 (0.56) RETFLT1KDRMAPK14HSD17B10
SCHEMBL29778657 0.85 PDPK1 (0.54) RETFLT1KDRMAPK14HSD17B10
SCHEMBL28215029 0.85 APP (0.45) RETFLT1KDRMAPK14HSD17B10
SCHEMBL21089184 0.85 APP (0.43) RETFLT1KDRMAPK14HSD17B10
SCHEMBL21089299 0.83 HSD17B1 (0.42) RETFLT1KDRMAPK14HSD17B10
SCHEMBL21089384 0.82 NPC1 (0.42) RETFLT1KDRMAPK14HSD17B10
SCHEMBL20477485 0.81 MAPT (0.44) RETFLT1KDRMAPK14HSD17B10
SCHEMBL28371764 0.81 RAB9A (0.44) RETFLT1KDRMAPK14HSD17B10
SCHEMBL21089192 0.81 ALDH1A1 (0.59) RETFLT1KDRMAPK14HSD17B10
SCHEMBL21089511 0.81 HPGD (0.48) HSD17B10ALDH1A1HPGDBCL2L1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11569461-B2 Organic electroluminescence device and organometallic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-01-31 US disclosed
US-20190181358-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANOMETALLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE LAPTO CO., LTD. (KR) 2019-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11569461-B2 Organic electroluminescence device and organometallic compound for organic electroluminescence device CHRM1, L1CAM, CHRM4 RET 2685/4885FLT1 3204/4885KDR 3488/4885
US-20190181358-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANOMETALLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE CHRM1, L1CAM, CHRM4 RET 2685/4885FLT1 3204/4885KDR 3488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.